Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan

Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan

(2014) S. Yokota et al.   JOURNAL OF RHEUMATOLOGY

Adult-Onset Still Disease

(2014) Mathieu Gerfaud-Valentin et al.   MEDICINE

Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease

(2014) Mio Mitamura et al.   Modern Rheumatology

Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan

(2014) Rie Suematsu et al.   Modern Rheumatology

Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease: Multicenter Retrospective Open-Label Study of Thirty-Four Patients

(2014) Francisco Ortiz-Sanjuán et al.   Arthritis & Rheumatology

Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence

(2012) Hubert de Boysson et al.   CLINICAL RHEUMATOLOGY

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Tocilizumab in refractory adult Still's disease

(2010) Xavier Puéchal et al.   ARTHRITIS CARE & RESEARCH